CENTREXION THERAPEUTICS CORP
Profile
Company Names
CENTREXION THERAPEUTICS CORP
CENTREXION CORP
Addresses
200 STATE STREET, 6TH FLOOR, BOSTON, MA 02109
200 STATE STREET, 6TH FLOOR, BOSTON, MA 02109
200 STATE STREET, BOSTON, MA 02109
509 S. EXETER ST., SUITE 202, BALTIMORE, MD 21202
Phone Numbers
617-837-6911
410-522-8701
212-956-1111
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2013
State Incorporated:
DELAWARE
Total Amount Raised:
$187,227,026.00
Number of Funding Rounds:
12
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
12
2023-12-28
$3,255,467.00
$12,859,762.00
$9,604,295.00
Debt
11
2023-11-14
$2,300,000.00
$2,300,000.00
$0.00
Debt
10
2023-06-14
$10,280,238.00
$30,000,000.00
$19,719,762.00
Debt
9
2022-05-24
$29,140,000.00
$29,140,000.00
$0.00
Debt
8
2021-01-12
$13,500,000.00
$13,500,000.00
$0.00
Debt
7
2017-12-18
$69,566,532.00
$69,566,532.00
$0.00
Equity
6
2017-04-28
$5,285,000.00
INDEFINITE
INDEFINITE
5
2016-12-30
$16,564,789.00
$16,564,789.00
$0.00
Equity
4
2016-06-14
$11,163,500.00
INDEFINITE
INDEFINITE
3
2016-04-08
$6,905,000.00
INDEFINITE
INDEFINITE
2
2016-03-01
$10,516,500.00
INDEFINITE
INDEFINITE
1
2013-11-20
$8,750,000.00
$8,750,000.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
SOL
BARER
DIRECTOR
SOL
J.
BARER
DIRECTOR
GREGG
BELOFF
EXECUTIVE OFFICER
ISAAC
BLECH
DIRECTOR
SOCIALWISE, INC. (FORMERLY KNOWN AS IDEAEDGE, INC)
| CONTRAFECT CORP
| BILLMYPARENTS, INC.
| CERECOR INC.
| MEDGENICS, INC.
| PREMIER ALLIANCE GROUP, INC.
| EDGE THERAPEUTICS, INC.
| SPENDSMART PAYMENTS CO
| CENTREXION CORP
| RESTORGENEX CORP
| ROOT9B TECHNOLOGIES INC.
| WAVEGUIDE CORP
| X4 PHARMACEUTICALS, INC.
| ROOT9B TECHNOLOGIES, INC.
| INSPIREMD, INC.
| CENTREXION THERAPEUTICS CORP
| SAPIENCE THERAPEUTICS, INC.
| ARIDIS PHARMACEUTICALS, INC.
| X-VAX TECHNOLOGY, INC.
| REGENOVATION, INC.
| DIFFUSION PHARMACEUTICALS INC.
| NACUITY PHARMACEUTICALS, INC.
| ELUCIDA ONCOLOGY, INC.
| MARINA BIOTECH, INC.
| ALVEO TECHNOLOGIES INC.
| VEDANTRA PHARMACEUTICALS, INC.
COLIN
HILL
DIRECTOR
JEFFREY
B.
KINDLER
EXECUTIVE OFFICER, DIRECTOR
SARA
NAYEEM
DIRECTOR
ARNOLD
ORONSKY
DIRECTOR
APPLIED GENETIC TECHNOLOGIES CORP
| ARCION THEREAPEUTICS INC
| DRAIS PHARMACEUTICALS INC
| ARCION THERAPEUTICS, INC.
| USDS, INC.
| MACROGENICS INC
| TESARO, INC.
| TELSAR PHARMA, INC.
| SELDAR PHARMA, INC.
| INTEGRATED DIAGNOSTICS, INC.
| POTENZA THERAPEUTICS, INC.
| VESUVIUS PHARMACEUTICALS, INC.
| PMV PHARMACEUTICALS, INC.
| CENTREXION THERAPEUTICS CORP
ARNOLD
L.
ORONSKY
DIRECTOR
MICHAEL
J.
WARD
EXECUTIVE OFFICER
PETER
WIRTH
DIRECTOR
STELLA
XU
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2023-12-28
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2023-11-14
D/A
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2023-06-14
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2023-06-14
D/A
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2022-05-24
D/A
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2022-05-24
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2022-05-24
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2021-01-12

